S

Solid Biosciences
D

SLDB

4.86000
USD
0.35
(7.64%)
مغلق
حجم التداول
42,991
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
376,724,732
أصول ذات صلة
BNTX
BNTX
1.950
(1.89%)
105.060 USD
C
CODX
0.01260
(4.89%)
0.27010 USD
I
IBIO
0.01480
(2.06%)
0.73300 USD
I
INO
0.12500
(6.48%)
2.05500 USD
MRNA
MRNA
1.110
(4.32%)
26.790 USD
N
NVAX
0.17500
(2.77%)
6.49500 USD
V
VXRT
-0.00580
(-1.03%)
0.56000 USD
المزيد
الأخبار المقالات

العنوان: Solid Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.